Functional outcome in patients with major depressive disorder treated by agomelatine 25-50 mg as compared to placebo
| Autor: | Kennedy, S.H. 1, Heun, R. 2, Avedisova, A.S. 3, Ahokas, A. 4, Olivier, V. 5, Picarel-Blanchot, F. 5, ⁎, De Bodinat, C. 5 |
|---|---|
| Zdroj: | In European Neuropsychopharmacology 2019 29 Supplement 1:S233-S234 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect